2007
DOI: 10.1016/j.pbb.2007.01.018
|View full text |Cite
|
Sign up to set email alerts
|

Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating

Abstract: Corticotropin-releasing factor (CRF), a neuropeptide released during stress, has been reported to modulate startle behavior, including reducing the threshold for acoustic startle responding and reducing prepulse inhibition (PPI). The central mechanisms mediating CRF system regulation of startle and PPI are still unclear. Some antipsychotic drugs attenuate CRF-induced deficits in PPI in rats and mice. Here we tested the hypothesis that indirect activation of DA 1 -receptors (D 1 ) and DA 2 -receptors (D 2 ) con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
18
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 90 publications
1
18
0
Order By: Relevance
“…This is noteworthy because dopamine receptor agonists can decrease PPI at some intervals and increase PPI at others [13, 55, 56, 59]. The present findings, along with those of Vinkers et al [36], showing that CRF decreases PPI in both D 1 and D 2 receptor knockout mice, suggests that CRF does not decrease PPI via an indirect effect on dopamine. However, there are data that suggest otherwise.…”
Section: Discussionsupporting
confidence: 77%
See 2 more Smart Citations
“…This is noteworthy because dopamine receptor agonists can decrease PPI at some intervals and increase PPI at others [13, 55, 56, 59]. The present findings, along with those of Vinkers et al [36], showing that CRF decreases PPI in both D 1 and D 2 receptor knockout mice, suggests that CRF does not decrease PPI via an indirect effect on dopamine. However, there are data that suggest otherwise.…”
Section: Discussionsupporting
confidence: 77%
“…For example, Meloni et al, [62] found that a selective D 1 receptor antagonist blocks the CRF-induced increase in startle amplitude. However, this is not so in mice, and both D 1 and D 2 receptor knockout mice show a CRF-induced increase in startle amplitude [36]. We have found that the effect of CRF on startle, but not PPI, is blocked by ketanserin, a 5-HT 2A/C antagonist [57].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For instance, increased dopamine transmission has been shown to increase startle responses (Davis and Aghajanian 1976; Davis 1980; Davis et al 1986) and dopamine D1 receptor activation mediates CRF effects on startle in rats (Meloni et al 2006). However, in mice CRF-induced startle is unaffected by the genetic disruption and pharmacological blockade of D1 or D2 receptors suggesting species differences in the signaling transduction pathways mediating CRF effects on startle (Vinkers et al 2007). In mice, we have found that noradrenergic transmission via α1 receptor activation plays a permissive role in CRFinduced startle hyperreactivity (Gresack and Risbrough 2011).…”
Section: Discussionmentioning
confidence: 99%
“…In fact, Meloni et al (2006a) reported that CRF-enhanced startle, in rats, is blocked by systemic injections of the D1 receptor antagonist SCH 23390. Vinkers et al (2007) were unable to replicate this in mice however, and also reported normal CRF-enhanced startle in D1-receptor knockouts. They suggested that species or dosage differences (including non-selectivity at the doses used by Meloni and colleagues) may have accounted for the different outcomes of those two studies.…”
Section: A Specific Neural Circuit For Sustained Fearmentioning
confidence: 92%